Literature DB >> 16292891

Cancer cells ablation with irreversible electroporation.

Liron Miller1, Jonathan Leor, Boris Rubinsky.   

Abstract

In this study we perform in vitro irreversible electroporation (IRE) experiments with human hepatocarcinoma cells (HepG2) to investigate IRE as a new technique for undesirable tissue ablation. Irreversible electroporation (IRE) is the irreversible permeabilization of the cell membrane through the application of microsecond through millisecond electrical pulses. Until now IRE was studied only as an undesirable condition during the use of reversible electroporation in gene therapy and electrochemotherapy. There was a possibility that the IRE ablation domain is mostly superimposed on the electrical pulses induced Joule heating thermal ablation domain. This study demonstrates that there is a real and substantial domain of electrical parameters for IRE ablation of cancer that is distinct from the thermal domain and which results in complete cancer cell ablation. Experiments show that the application of 1500 V/cm in three sets of ten pulses of 300 microseconds each can produce complete cancer cell ablation. We also find that the use of multiple pulses appears to be more effective for cancer cell ablation than the application of the same energy in one single pulse.

Entities:  

Mesh:

Year:  2005        PMID: 16292891     DOI: 10.1177/153303460500400615

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  65 in total

1.  Real-time ultrasound imaging of irreversible electroporation in a porcine liver model adequately characterizes the zone of cellular necrosis.

Authors:  Carl R Schmidt; Peter Shires; Mary Mootoo
Journal:  HPB (Oxford)       Date:  2011-11-16       Impact factor: 3.647

Review 2.  Irreversible Electroporation.

Authors:  Govindarajan Narayanan
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

3.  Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Authors:  Zhuoli Zhang; Weiguo Li; Daniel Procissi; Patrick Tyler; Reed A Omary; Andrew C Larson
Journal:  Nanomedicine (Lond)       Date:  2013-09-11       Impact factor: 5.307

4.  Diffusion MRI biomarkers predict the outcome of irreversible electroporation in a pancreatic tumor mouse model.

Authors:  Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Bin Wang; Chong Sun; Junjie Shangguan; Liang Pan; Kang Zhou; Quanhong Ma; Vahid Yaghmai; Daniele Procissi; Andrew C Larson; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

5.  Effects of electrically-induced constant tension on giant unilamellar vesicles using irreversible electroporation.

Authors:  Mohammad Abu Sayem Karal; Md Kabir Ahamed; Mostafizur Rahman; Marzuk Ahmed; Md Mostofa Shakil; Khondkar Siddique-E-Rabbani
Journal:  Eur Biophys J       Date:  2019-09-24       Impact factor: 1.733

6.  Irreversible electroporation for microbial control of drugs in solution.

Authors:  Alex Golberg; Michael Belkin; Boris Rubinsky
Journal:  AAPS PharmSciTech       Date:  2009-07-02       Impact factor: 3.246

Review 7.  Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future.

Authors:  L M Mir
Journal:  Mol Biotechnol       Date:  2009-06-27       Impact factor: 2.695

Review 8.  New Approaches in Locoregional Therapies for Hepatocellular Carcinoma.

Authors:  Riccardo Memeo; Vito de Blasi; Zineb Cherkaoui; Ammar Dehlawi; Nicola De' Angelis; Tullio Piardi; Daniele Sommacale; Jacques Marescaux; Didier Mutter; Patrick Pessaux
Journal:  J Gastrointest Cancer       Date:  2016-09

Review 9.  Interventional oncology: the future.

Authors:  Fredric A Hoffer
Journal:  Pediatr Radiol       Date:  2011-04-27

10.  Irreversible electroporation of the liver and liver hilum in swine.

Authors:  Kevin P Charpentier; Farrah Wolf; Lelia Noble; Brody Winn; Murray Resnick; Damian E Dupuy
Journal:  HPB (Oxford)       Date:  2011-01-25       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.